• Commercialization
    • Regulatory Strategy
    • Reimbursement
    • Medical Device Due Diligence
    • Medical Device Market Analysis
  • Medical Device Services
      • Quality Management
      • Quality Management Systems: ISO 13485
      • Quality manager
      • Person Responsible for Regulatory Compliance (PRRC)
      • Auditing for Quality Management Systems and Technical Files
      • Technical File
      • Medical Device Technical Files for EU CE Marking
      • Clinical Evaluation Reports (CER) under the EU MDR
      • Biological Evaluation Reports (BER) under the EU MDR
      • FDA Approval Process for Medical Devices
      • Consulting
      • Quality Assurance and Regulatory Consulting
      • European Authorized Representative
      • Medical Device Testing: ISO 10993
      • Medical Device Testing: IEC 60601
      • Medical Device and Quality Management Training
  • CRO
    • CRO Services – Project Management
    • CRA and Monitoring
    • Auditing Services and Quality Management for Clinical Trials
    • Good Laboratory Practice (GLP) Studies
  • IPR
  • Product & Compliance
    • Development of Medical Device Software
    • Cyber Resilience Act (CRA) Services
    • AI Act (Artificial Intelligence Act) Services
  • Blog
  • Contact details

Waltteri Sorvisto

The Medical Device Startup Playbook: Set the Direction Early

by Waltteri Sorvisto | May 7, 2026 | Medical Device Services

Medical device development often begins with a strong technical idea. For startups, that early momentum is important. A prototype, a clinical need, or a promising technology can create the energy needed to move a product forward. But in medical device development,...

Developing medical software with clinical and regulatory alignment

by Waltteri Sorvisto | Apr 29, 2026 | Product & Compliance

Medical device software is often discussed primarily as a development challenge. The focus tends to be on functionality, performance, architecture, and how the final product will behave in use. All of that matters. But in regulated environments, software development...

Why Freedom to Operate matters earlier than many companies think

by Waltteri Sorvisto | Apr 23, 2026 | IPR

In product development, intellectual property is often discussed relatively late. The conversation tends to begin when an invention is ready to be protected, a filing strategy is taking shape, or external investors start asking how the company plans to defend its...

EUDAMED deadlines are approaching. What medical device companies should do now

by Waltteri Sorvisto | Apr 16, 2026 | Medical Device Services

For medical device and IVD manufacturers in Europe, EUDAMED is moving from something to prepare for into something that must be actively managed. The timeline is now clear. Following the European Commission’s notice that the first four EUDAMED modules are functional,...

Understanding the Cyber Resilience Act: From Requirements to Practical Implementation

by Waltteri Sorvisto | Apr 9, 2026 | Commerzialisation

The Cyber Resilience Act (CRA) introduces a new layer of requirements for products with digital elements, with the goal of improving cybersecurity across the EU market. For many companies, the structure of CRA will feel familiar. It places responsibility on...
« Older Entries
Next Entries »

Recent Posts

  • How External QA/RA Expertise Can Strengthen Your Internal Team
  • When Does a Medical Device Company Need CRO Support?
  • Summer at MDS: Keeping QA/RA Work Moving
  • Why MedTech Companies Should Plan IP Strategy Beyond the First Filing
  • MDS Blog Taking a Short Summer Break

Recent Comments

No comments to show.

CONTACT US

kristian@mdsdenmark.dk
+45 2712 4712

Book a meeting

Specialised Services For Medical Device Industry

MDS Denmark

Østerbrogade 56A, 1. th,
2100 København Ø

Privacy policy

CONTACT US

+45 2712 4712
Kristian@mdsdenmark.dk